Abstract
The expression of ABO(H) blood group antigens causes deletion of cells that generate self-specific antibodies to these antigens but this deletion limits adaptive immunity toward pathogens bearing cognate blood group antigens. To explore potential defense mechanisms against such pathogens, given these limitations in adaptive immunity, we screened for innate proteins that could recognize human blood group antigens. Here we report that two innate immune lectins, galectin-4 (Gal-4) and Gal-8, which are expressed in the intestinal tract, recognize and kill human blood group antigen–expressing Escherichia coli while failing to alter the viability of other E. coli strains or other Gram-negative or Gram-positive organisms both in vitro and in vivo. The killing activity of both Gal-4 and Gal-8 is mediated by their C-terminal domains, occurs rapidly and independently of complement and is accompanied by disruption of membrane integrity. These results demonstrate that innate defense lectins can provide immunity against pathogens that express blood group–like antigens on their surface (pages 263 –264).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
£139.00 per year
only £11.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Rowe, J.A. et al. Blood group O protects against severe Plasmodium falciparum malaria through the mechanism of reduced rosetting. Proc. Natl. Acad. Sci. USA 104, 17471–17476 (2007).
Yamamoto, F., Clausen, H., White, T., Marken, J. & Hakomori, S. Molecular genetic basis of the histo-blood group ABO system. Nature 345, 229–233 (1990).
Cash, H.L., Whitham, C.V., Behrendt, C.L. & Hooper, L.V. Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science 313, 1126–1130 (2006).
Figdor, C.G., van Kooyk, Y. & Adema, G.J. C-type lectin receptors on dendritic cells and Langerhans cells. Nat. Rev. Immunol. 2, 77–84 (2002).
van Kooyk, Y. & Rabinovich, G.A. Protein-glycan interactions in the control of innate and adaptive immune responses. Nat. Immunol. 9, 593–601 (2008).
Stowell, S.R. et al. Galectin-1, -2, and -3 exhibit differential recognition of sialylated glycans and blood group antigens. J. Biol. Chem. 283, 10109–10123 (2008).
Stowell, S.R. et al. Dimeric Galectin-8 induces phosphatidylserine exposure in leukocytes through polylactosamine recognition by the C-terminal domain. J. Biol. Chem. 283, 20547–20559 (2008).
Reeves, P. Role of O-antigen variation in the immune response. Trends Microbiol. 3, 381–386 (1995).
Springer, G.F., Williamson, P. & Brandes, W.C. Blood group activity of Gram-negative bacteria. J. Exp. Med. 113, 1077–1093 (1961).
Springer, G.F. & Horton, R.E. Blood group isoantibody stimulation in man by feeding blood group–active bacteria. J. Clin. Invest. 48, 1280–1291 (1969).
Garratty, G. Blood groups and disease: a historical perspective. Transfus. Med. Rev. 14, 291–301 (2000).
Yi, W. et al. Escherichia coli O86 O-antigen biosynthetic gene cluster and stepwise enzymatic synthesis of human blood group B antigen tetrasaccharide. J. Am. Chem. Soc. 127, 2040–2041 (2005).
Wooters, M.A., Hildreth, M.B., Nelson, E.A. & Erickson, A.K. Immunohistochemical characterization of the distribution of galectin-4 in porcine small intestine. J. Histochem. Cytochem. 53, 197–205 (2005).
Vasta, G.R. Roles of galectins in infection. Nat. Rev. Microbiol. 7, 424–438 (2009).
Kohatsu, L., Hsu, D.K., Jegalian, A.G., Liu, F.T. & Baum, L.G. Galectin-3 induces death of Candida species expressing specific β-1,2-linked mannans. J. Immunol. 177, 4718–4726 (2006).
Thiel, S. et al. A second serine protease associated with mannan-binding lectin that activates complement. Nature 386, 506–510 (1997).
Eshkar Sebban, L. et al. The involvement of CD44 and its novel ligand galectin-8 in apoptotic regulation of autoimmune inflammation. J. Immunol. 179, 1225–1235 (2007).
Hadari, Y.R. et al. Galectin-8. A new rat lectin, related to galectin-4. J. Biol. Chem. 270, 3447–3453 (1995).
Ribi, H.O., Ludwig, D.S., Mercer, K.L., Schoolnik, G.K. & Kornberg, R.D. Three-dimensional structure of cholera toxin penetrating a lipid membrane. Science 239, 1272–1276 (1988).
Houzelstein, D. et al. Phylogenetic analysis of the vertebrate galectin family. Mol. Biol. Evol. 21, 1177–1187 (2004).
Guo, H. et al. Molecular analysis of the O-antigen gene cluster of Escherichia coli O86:B7 and characterization of the chain length determinant gene (wzz). Appl. Environ. Microbiol. 71, 7995–8001 (2005).
Gitt, M.A. et al. Galectin-4 and galectin-6 are two closely related lectins expressed in mouse gastrointestinal tract. J. Biol. Chem. 273, 2954–2960 (1998).
Hansson, G.C. Structural aspects of blood group glycosphingolipids in the gastrointestinal tract. Adv. Exp. Med. Biol. 228, 465–494 (1988).
Hoskins, L.C. & Boulding, E.T. Degradation of blood group antigens in human colon ecosystems. I. In vitro production of ABH blood group–degrading enzymes by enteric bacteria. J. Clin. Invest. 57, 63–73 (1976).
Hoskins, L.C. & Boulding, E.T. Degradation of blood group antigens in human colon ecosystems. II. A gene interaction in man that affects the fecal population density of certain enteric bacteria. J. Clin. Invest. 57, 74–82 (1976).
Larson, G., Watsfeldt, P., Falk, P., Leffler, H. & Koprowski, H. Fecal excretion of intestinal glycosphingolipids by newborns and young children. FEBS Lett. 214, 41–44 (1987).
Huflejt, M.E. & Leffler, H. Galectin-4 in normal tissues and cancer. Glycoconj. J. 20, 247–255 (2004).
Nagy, N. et al. Galectin-8 expression decreases in cancer compared with normal and dysplastic human colon tissue and acts significantly on human colon cancer cell migration as a suppressor. Gut 50, 392–401 (2002).
Lindén, S. et al. Role of ABO secretor status in mucosal innate immunity and H. pylori infection. PLoS Pathog. 4, e2 (2008).
Stowell, S.R. et al. Galectin-1 induces reversible phosphatidylserine exposure at the plasma membrane. Mol. Biol. Cell 20, 1408–1418 (2009).
Blixt, O. et al. Printed covalent glycan array for ligand profiling of diverse glycan binding proteins. Proc. Natl. Acad. Sci. USA 101, 17033–17038 (2004).
Acknowledgements
We thank S. Cummings and M. Willard for technical assistance. We also thank P.G. Wang (Ohio State University) for providing the original E. coli O86:B7 strain, as well as the α-Gal bacteria mutant versions of this strain lacking expression of either the wzy or waaL genes. We obtained P. aeruginosa strain 8830 from A. Chakrabaty (University of Illinois College of Medicine) and plasmid pSMC21 encoding GFP from G. O'Toole (Dartmouth Medical School). We also thank the staff at the Robert P. Apkarian Integrated Electron Microscopy Core Facility at Emory University for their help with electron microscopy. This work was supported by grants from the US National Institutes of Health to R.D.C. (HL085607) and D.F.S. (GM085448) and by resources from the Consortium for Functional Glycomics (Core D and Core H), funded by the US National Institute of General Medical Sciences/US National of Institutes of Health (GM62116).
Author information
Authors and Affiliations
Contributions
S.R.S. and C.M.A. planned the project along with R.D.C. and carried out and analyzed the experiments, together with M.D.-B., L.C.R., J.-P.G., J.H.-M., B.X., C.R.-M., T.J., R.J.M. and D.F.S., who also helped to perform the experiments and provided crucial support. S.R.S., C.M.A., J.H.-M. and R.D.C. wrote the manuscript, which was additionally edited and commented on by the other authors.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Text and Figures
Supplementary Figure 1, Supplementary Table 1 and Supplementary Methods (PDF 1018 kb)
Supplementary Video 1
Immobilization of BGB+ E. coli after addition of Gal-8. BGB+ E. coli observed in real time before and after addition of 5 μM Gal-8 at approximately 20 s. Bacteria show normal movement and viability before addition of galectin and loss of mobility immediately after Gal-8 treatment. (MOV 19257 kb)
Rights and permissions
About this article
Cite this article
Stowell, S., Arthur, C., Dias-Baruffi, M. et al. Innate immune lectins kill bacteria expressing blood group antigen. Nat Med 16, 295–301 (2010). https://doi.org/10.1038/nm.2103
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.2103
This article is cited by
-
Whole microbe arrays accurately predict interactions and overall antimicrobial activity of galectin-8 toward distinct strains of Streptococcus pneumoniae
Scientific Reports (2023)
-
Immune regulatory networks coordinated by glycans and glycan-binding proteins in autoimmunity and infection
Cellular & Molecular Immunology (2023)
-
The role of galectins in immunity and infection
Nature Reviews Immunology (2023)
-
A novel serum spherical lectin from lamprey reveals a more efficient mechanism of immune initiation and regulation in jawless vertebrates
Cellular & Molecular Biology Letters (2022)
-
Regulation of wound healing and fibrosis by galectins
Journal of Molecular Medicine (2022)